These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 2569989
21. [Effect of synthetic fragments of thymic peptide hormones on learning and memory processes]. Martynov VF, Leont'eva LI, Sorochinskaia EI. Fiziol Zh SSSR Im I M Sechenova; 1988 May; 74(5):634-9. PubMed ID: 3417026 [Abstract] [Full Text] [Related]
22. [The protective action of thymopentin on stress damage to the stomach]. Deviatkina TA, Tarasenko LM, Klusha VE, Tsebrzhinskiĭ OI, Mutsenietse RK. Biull Eksp Biol Med; 1989 Jun; 107(6):673-5. PubMed ID: 2676006 [Abstract] [Full Text] [Related]
23. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs? Consoli D, Leggio GM, Mazzola C, Micale V, Drago F. Eur J Pharmacol; 2007 Nov 14; 573(1-3):139-47. PubMed ID: 17669397 [Abstract] [Full Text] [Related]
24. Effects of thymopoietin pentapeptide (TP-5) on in vitro and in vivo IgE production by atopic dermatitis cell subsets. Cooper KD, Kang K, Hanifin JM. Diagn Immunol; 1983 Nov 14; 1(3):211-5. PubMed ID: 6388971 [Abstract] [Full Text] [Related]
25. The effect of thymic substances on T circulating cells of patients treated for Hodgkin's disease. Chisesi T, Capnist G, Rancan L, Pellizzari G, Vespignani M. J Biol Regul Homeost Agents; 1988 Nov 14; 2(4):193-8. PubMed ID: 3074627 [Abstract] [Full Text] [Related]
27. Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination. Záruba K, Rastorfer M, Grob PJ, Joller-Jemelka H, Bolla K. Lancet; 1983 Nov 26; 2(8361):1245. PubMed ID: 6139582 [No Abstract] [Full Text] [Related]
30. The role of the reticulo-epithelial (RE) cell network in the immuno-neuroendocrine regulation of intrathymic lymphopoiesis. Bodey B, Bodey B, Siegel SE, Kaiser HE. Anticancer Res; 2000 Nov 26; 20(3A):1871-88. PubMed ID: 10928121 [Abstract] [Full Text] [Related]
31. Anxiolytic- and antidepressant-like effects of an antagonist at glycineB receptors. Przegaliński E, Tatarczyńska E, Chojnacka-Wójcik E. Pol J Pharmacol; 1998 Nov 26; 50(4-5):349-54. PubMed ID: 10091720 [Abstract] [Full Text] [Related]
32. Effects of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients.-II) In vivo study. Auteri A, Laghi Pasini F, Pasqui AL, Bilenchi R, Di Perri T. Boll Soc Ital Biol Sper; 1980 Feb 29; 56(4):312-5. PubMed ID: 7018515 [No Abstract] [Full Text] [Related]
33. Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonist. Simiand J, Keane PE, Barnouin MC, Keane M, Soubrié P, Le Fur G. Fundam Clin Pharmacol; 1993 Feb 29; 7(8):413-27. PubMed ID: 7904976 [Abstract] [Full Text] [Related]
34. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents. Khisti RT, Deshpande LS, Chopde CT. Psychopharmacology (Berl); 2002 May 29; 161(2):120-8. PubMed ID: 11981591 [Abstract] [Full Text] [Related]
35. Immunomodulation with thymopentin: in vitro studies. Duchateau J, Bolla K. Med Oncol Tumor Pharmacother; 1989 May 29; 6(1):19-23. PubMed ID: 2657246 [Abstract] [Full Text] [Related]
36. On the mechanism of antidepressant-like action of berberine chloride. Kulkarni SK, Dhir A. Eur J Pharmacol; 2008 Jul 28; 589(1-3):163-72. PubMed ID: 18585703 [Abstract] [Full Text] [Related]
37. Stimulation by thymopoietin oligopeptides of lectin-dependent cell-mediated cytotoxicity in patients with systemic lupus erythematosus. Perl A, Gonzalez-Cabello R, Nékám K, Gergely P, Fehér J. J Clin Lab Immunol; 1985 Nov 28; 18(3):119-22. PubMed ID: 3910838 [Abstract] [Full Text] [Related]
38. Thymic hormones and the immune system. Wara DW. Adv Pediatr; 1981 Nov 28; 28():229-70. PubMed ID: 6280461 [No Abstract] [Full Text] [Related]
39. Restoration of the impaired lymphocyte stimulation in old people by thymopoietin pentapeptide. Verhaegen H, De Cock W, De Cree J, Goldstein G. J Clin Lab Immunol; 1981 Sep 28; 6(2):103-5. PubMed ID: 7026790 [Abstract] [Full Text] [Related]
40. Prevention of graft-vs-host reaction induced immunodeficiency by treatment with splenopentin (DAc-SP5). Eckert R, Volk HD, Diezel W, Maciewski J, Hiepe F, Forner K, von Baehr R. Allerg Immunol (Leipz); 1989 Sep 28; 35(4):279-85. PubMed ID: 2624251 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]